Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy.
Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy.
复制标题
注射技术、药物配方及肿瘤微环境对肿瘤内免疫治疗递送及疗效的影响。
DOI:
10.1136/jitc-2020-001800
复制
发表时间:
2021-03
影响因子:
10.9
通讯作者:
Sheth RA
中科院分区:
文献类型:
--
作者:
Muñoz NM;Williams M;Dixon K;Dupuis C;McWatters A;Avritscher R;Manrique SZ;McHugh K;Murthy R;Tam A;Naing A;Patel SP;Leach D;Hartgerink JD;Young S;Prakash P;Hwu P;Sheth RA
Intratumoral delivery of immunotherapeutics represents a compelling solution to directly address local barriers to tumor immunity. However, we have previously shown that off-target delivery is a substantial problem during intratumoral injections; this can lead to diminished drug efficacy and systemic toxicities. We have identified three variables that influence intratumoral drug delivery: injection technique, drug formulation and tumor microenvironment. The purpose of this study was to characterize the impact of modifications in each variable on intratumoral drug delivery and immunotherapy efficacy. Intratumoral injections were performed in a hybrid image-guided intervention suite with ultrasound, fluoroscopy and CT scanning capabilities in both rat and mouse syngeneic tumor models. Intratumoral drug distribution was quantified by CT volumetric imaging. The influence of varying needle design and hydrogel-based drug delivery on the immune response to a stimulator of interferon genes (STING) agonist was evaluated using flow cytometry and single cell RNA sequencing. We also evaluated the influence of tumor stiffness on drug injection distribution. Variations in needle design, specifically with the use of a multiside hole needle, led to approximately threefold improvements in intratumoral drug deposition relative to conventional end-hole needles. Likewise, delivery of a STING agonist through a multiside hole needle led to significantly increased expression of type I interferon-associated genes and ‘inflammatory’ dendritic cell gene signatures relative to end-hole STING agonist delivery. A multidomain peptide-based hydrogel embedded with a STING agonist led to substantial improvements in intratumoral deposition; however, the hydrogel was noted to generate a strong immune response against itself within the target tumor. Evaluation of tumor stroma on intratumoral drug delivery revealed that there was a greater than twofold improvement in intratumoral distribution in soft tumors (B16 melanoma) compared with firm tumors (MC38 colorectal). Injection technique, drug formulation and tumor stiffness play key roles in the accurate delivery of intratumoral immunotherapeutics.
登录
查看更多内容
影响因子:
4.6
作者:
Bankhead P;Loughrey MB;Fernández JA;Dombrowski Y;McArt DG;Dunne PD;McQuaid S;Gray RT;Murray LJ;Coleman HG;James JA;Salto-Tellez M;Hamilton PW
通讯作者:
Hamilton PW
影响因子:
5.8
作者:
Leach DG;Newton JM;Florez MA;Lopez-Silva TL;Jones AA;Young S;Sikora AG;Hartgerink JD
通讯作者:
Hartgerink JD
影响因子:
8.8
作者:
Corrales L;Glickman LH;McWhirter SM;Kanne DB;Sivick KE;Katibah GE;Woo SR;Lemmens E;Banda T;Leong JJ;Metchette K;Dubensky TW Jr;Gajewski TF
通讯作者:
Gajewski TF
影响因子:
10.1
作者:
Farsaci B;Donahue RN;Coplin MA;Grenga I;Lepone LM;Molinolo AA;Hodge JW
通讯作者:
Hodge JW
影响因子:
28.1
作者:
Wang F;Su H;Xu D;Dai W;Zhang W;Wang Z;Anderson CF;Zheng M;Oh R;Wan F;Cui H
通讯作者:
Cui H